GREY:ATBPF - Post by User
Post by
nozzpackon Aug 10, 2021 8:03pm
202 Views
Post# 33682812
Market Cap to Ebitda for ATE Citagenix
Market Cap to Ebitda for ATE Citagenix The 2021 multiple of EV to Ebitda for drug pharmaceuticals 14.5 times.
As Citagenix has no debt, Market cap= EV
Ebitda in 2020 was $3.0 million.
However, revenues in Q1 of 2020 was just $1.2 million due to Covid lockdowns.
The remaining three quarters were solidly $2.8 m in sales per quarter.
Adjusting those 3 quarters for a full year and annual sales would have been close to $11,5 million and Ebitda of about $3.6 m.
So, using $3.6 million times 14.5 which equals Approx $47 million market cap or about $0,90 per share.
Average the two peer based estimates and Citagenix is worth about $1.00 per share
https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/